First Header Logo Second Header Logo

Connection

Samuel Lentz to Follow-Up Studies

Back to Details
This is a "connection" page, showing publications Samuel Lentz has written about Follow-Up Studies.
Samuel Lentz
Connection Strength
0.042
Follow-Up Studies
  1. Kelly MG, Winkler SS, Lentz SS, Berliner SH, Swain MF, Skinner HG, Schwartz GG. Serum Calcium and Serum Albumin Are Biomarkers That Can Discriminate Malignant from Benign Pelvic Masses. Cancer Epidemiol Biomarkers Prev. 2015 Oct; 24(10):1593-8.
    View in: PubMed
    Score: 0.022
  2. Berek JS, Edwards RP, Parker LP, DeMars LR, Herzog TJ, Lentz SS, Morris RT, Akerley WL, Holloway RW, Method MW, Plaxe SC, Walker JL, Friccius-Quecke H, Krasner CN. Catumaxomab for the treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: a phase II study. Int J Gynecol Cancer. 2014 Nov; 24(9):1583-9.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.